Equity Performance News Today

The month ends on Feb 29

Complexity, capital calls, and illiquidity are among the challenges investors face to reap potential rewards.

Global equity markets have ended the year 2023 on a higher note. Major global equity benchmarks have given double-digit returns

Soaring U.S. Treasury yields are further boosting the appeal of bonds over stocks, deepening an already painful equity selloff while threatening to weigh on equity performance over the long term. Bond yields near historic lows bolstered the attractiveness of stocks over the past 15 years, when the U.S. Federal Reserve kept rates near zero to support the economy following the 2008 financial crisis. This year’s climb in Treasury yields is changing that calculus, as government bonds offer ...

Jitters about a systemic banking crisis have begun to ease as recent data has shown less reliance on emergency lending facilities set up in the wake of March’s banking turmoil.

This article reviews some of Most viewed videos posted by the top five cryptocurrency YouTube channels, Coin Bureau, Altcoin Daily, CryptosRUs, Ellio

While growth, earnings, and liquidity conditions are expected to remain highly supportive to risk assets, given strong returns this year and stretched valuations, some volatility (which we’re already experiencing) is likely over the coming months.

Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation Equity Performance: from Sonic Fund letter to Adverum Equity Performance: from Sonic Fund letter to Adverum Image 1: from Sonic Fund letter to Adverum Image 1: from Sonic Fund letter to Adverum Image 2: from Sonic Fund letter to Adverum Image 2: from Sonic Fund letter to Adverum Image 3: from Sonic Fund letter to Adverum Image 3: from Sonic Fund letter to Adverum Image 4: from Sonic Fun...

Dear Joe: As you are aware, our firm, Glenview Capital Management, has been a top shareholder of Bausch Health Companies ("BHC", "Bausch", or the "Company") since late-2018 and remains so today.  At present, we own more than 21 million shares, or approximately 6% of the Company, primarily in voting securities.  On behalf of shareholders, we begin by thanking the women and men of Bausch for their efforts in promoting global health throughout the pandemic and recognize their resilience throug...